• Nu Skin Enterprises swung to a third-quarter 2026 loss of $0.02 per share from a year-earlier profit.
• Revenue fell 15% year-over-year to $311.01 million, while customers declined 18% to 609,469.
• Management reported continued adoption of Prysm iO, including year-to-date revenue growth for LifePak nutritional supplements.
• Fourth-quarter 2026 guidance projects revenue of $310 million to $340 million, with earnings per share of $0.05 to $0.15.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nu Skin Enterprises Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611051606BIZWIRE_USPR_____20261105_BW090134) on November 05, 2026, and is solely responsible for the information contained therein.